James J Moon Selected Research

James J Moon Research Topics

Disease

56	Neoplasms (Cancer) 05/2024 - 09/2010
14	Inflammation (Inflammations) 12/2023 - 12/2011
11	Infections 04/2024 - 01/2009
10	Bites and Stings (Sting) 04/2024 - 10/2019
9	Melanoma (Melanoma, Malignant) 11/2022 - 01/2018
7	Carcinoma (Carcinomatosis) 03/2024 - 01/2017
6	COVID-19 04/2024 - 10/2020
6	Glioma (Gliomas) 01/2021 - 01/2020
4	Virus Diseases (Viral Diseases) 01/2023 - 01/2019
3	Lung Injury 02/2023 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2021
3	Communicable Diseases (Infectious Diseases) 10/2021 - 01/2009
3	Atherosclerotic Plaque (Atheroma) 10/2021 - 03/2016
3	Asthma (Bronchial Asthma) 10/2016 - 12/2011
3	Tuberculosis (Tuberculoses) 01/2014 - 11/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 11/2013
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 12/2021
2	Colitis 01/2022 - 01/2020
2	Atherosclerosis 10/2021 - 02/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2019
2	Ischemia 12/2018 - 01/2018
2	Adrenocortical Carcinoma 01/2017 - 01/2016
2	Malaria 01/2012 - 01/2012
1	Breast Neoplasms (Breast Cancer) 03/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024
1	Non-alcoholic Fatty Liver Disease 01/2024
1	Fibrosis (Cirrhosis) 01/2024
1	Dysbiosis 01/2024
1	Hypersensitivity (Allergy) 01/2024
1	Multiple Sclerosis 12/2023
1	Autoimmune Diseases (Autoimmune Disease) 12/2023
1	Rheumatoid Arthritis 12/2023
1	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 01/2023
1	Arthritis (Polyarthritis) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Lyme Disease (Disease, Lyme) 01/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022

Drug/Important Bio-Agent (IBA)

26	VaccinesIBA 04/2024 - 01/2009
22	AntigensIBA 04/2024 - 11/2010
13	Peptides (Polypeptides)IBA 02/2023 - 01/2010
11	HDL LipoproteinsIBA 10/2021 - 01/2016
10	Immune Checkpoint InhibitorsIBA 01/2023 - 08/2015
8	CytokinesIBA 01/2023 - 02/2009
7	NanovaccinesIBA 03/2021 - 01/2012
6	LipidsIBA 03/2024 - 01/2012
6	InterferonsIBA 03/2024 - 10/2020
6	Cancer VaccinesIBA 08/2021 - 08/2015
5	EpitopesIBA 01/2023 - 08/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 01/2018
4	ManganeseIBA 03/2024 - 11/2021
4	Hyaluronic Acid (Hyaluronan)IBA 01/2024 - 06/2015
4	CholesterolIBA 10/2021 - 01/2016
4	AllergensIBA 11/2020 - 01/2016
4	Liposomes (Liposome)IBA 01/2020 - 06/2015
3	BilirubinIBA 01/2024 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2019
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2023 - 10/2019
3	Transcription Factors (Transcription Factor)IBA 11/2022 - 01/2019
3	Interleukin-2 (IL2)IBA 11/2022 - 01/2019
3	Interleukin-17 (Interleukin 17)IBA 10/2022 - 09/2011
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2020 - 08/2015
3	Immunoglobulin G (IgG)IBA 09/2020 - 01/2018
3	Scavenger Receptors (Scavenger Receptor)IBA 12/2019 - 08/2017
2	Interferon Type IIBA 03/2024 - 01/2023
2	Cytidine Monophosphate (CMP)IBA 03/2024 - 11/2021
2	AutoantigensIBA 02/2023 - 01/2023
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 10/2021
2	Neutralizing AntibodiesIBA 10/2021 - 01/2019
2	Apolipoproteins E (ApoE)IBA 10/2021 - 02/2018
2	Liver X ReceptorsIBA 10/2021 - 02/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2020
2	NanoconjugatesIBA 12/2019 - 05/2018
2	withalongolide A 4,19,27-triacetateIBA 12/2019 - 01/2017
2	Biocompatible Materials (Biomaterials)IBA 10/2019 - 10/2019
1	PrebioticsIBA 05/2024
1	cyclic diadenosine phosphateIBA 03/2024
1	Amino Acids FDA Link 01/2024
1	AntioxidantsIBA 01/2024
1	Choline (Choline Chloride)IBA 01/2024
1	CollagenIBA 01/2024
1	HLA-DRB1*04 antigenIBA 01/2023
1	HLA-DR Antigens (HLA-DR)IBA 01/2023
1	Extracellular Matrix ProteinsIBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 11/2022
1	InterleukinsIBA 11/2022
1	Aldehyde DehydrogenaseIBA 11/2022
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 11/2022
1	oxidized low density lipoproteinIBA 11/2022
1	LectinsIBA 10/2022

Therapy/Procedure

32	Immunotherapy 05/2024 - 08/2015
31	Therapeutics 05/2024 - 01/2009
8	Drug Therapy (Chemotherapy) 05/2024 - 01/2018
3	Radiotherapy 05/2024 - 10/2019
3	Precision Medicine 12/2020 - 10/2019
2	Intravenous Administration 03/2024 - 10/2019
2	Photothermal Therapy 08/2021 - 01/2018
2	Limb Salvage 12/2018 - 01/2018
1	Oral Administration 05/2024